Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
The Vitamin D metabolism score, reflecting the combined levels of calcifediol and calcitriol, also increased in a dose-dependent manner following camel milk administration (Fig. 3B).
Source: Biochemical analysis. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Animal research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Within each sex, rats were randomly allocated into five experimental groups (n = 5 per group per sex):
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Dose-dependent effects of camel milk on immune function and metabolic health in weaning rats
Study design awaiting verification · Scientific Reports · 2026
Original publication title
Dose-dependent effects of camel milk on immune function and metabolic health in weaning rats
© The Author(s) 2026
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Breastfeeding cannot fulfill an infant’s nutritional needs beyond six months, necessitating the introduction of alternative milk sources. Camel milk has emerged as a promising candidate due to its rich profile of nutrients and immunomodulatory properties. This study evaluated the dose-dependent effects of camel milk on general health and immune response in post-weaning rats, with particular attention to sex-specific differences. Male and female rats were divided into: control (GI), and four treatment groups receiving 2.4 mL (GII), 3.4 mL (GIII), 4.4 mL (GIV), or 5.4 mL (GV) of camel milk daily for six weeks.
Serum biochemical parameters, including lipid profile, liver and kidney function markers, and immunological responses were assessed before and after immunization with sheep red blood cells. While higher doses (4.4 to 5.4 mL) significantly enhanced immune response and bone health, they concurrently elevated liver and kidney function parameters. The 3.4 mL dose balanced benefits, showing significant immune enhancement and bone health improvement without adverse metabolic effects. These findings demonstrated that camel milk (3.4 mL for rats/473 mL for infants) safely enhanced immune function, while higher doses risk metabolic stress.
The results supported camel milk’s potential as a nutritional supplement during weaning but emphasized the importance of dose regulation.
Supplementary Information
The online version contains supplementary material available at 10.1038/s41598-026-35775-0.
Authors’ abstract
Breastfeeding cannot fulfill an infant’s nutritional needs beyond six months, necessitating the introduction of alternative milk sources. Camel milk has emerged as a promising candidate due to its rich profile of nutrients and immunomodulatory properties. This study evaluated the dose-dependent effects of camel milk on general health and immune response in post-weaning rats, with particular attention to sex-specific differences. Male and female rats were divided into: control (GI), and four treatment groups receiving 2.4 mL (GII), 3.4 mL (GIII), 4.4 mL (GIV), or 5.4 mL (GV) of camel milk daily for six weeks.
Serum biochemical parameters, including lipid profile, liver and kidney function markers, and immunological responses were assessed before and after immunization with sheep red blood cells. While higher doses (4.4 to 5.4 mL) significantly enhanced immune response and bone health, they concurrently elevated liver and kidney function parameters. The 3.4 mL dose balanced benefits, showing significant immune enhancement and bone health improvement without adverse metabolic effects. These findings demonstrated that camel milk (3.4 mL for rats/473 mL for infants) safely enhanced immune function, while higher doses risk metabolic stress.
The results supported camel milk’s potential as a nutritional supplement during weaning but emphasized the importance of dose regulation.
Supplementary Information
The online version contains supplementary material available at 10.1038/s41598-026-35775-0.
Publication and source details
Original title: Dose-dependent effects of camel milk on immune function and metabolic health in weaning rats
Alyaa Farid; Mahy Mohamed; Maryam Amr; Gehan Safwat
Scientific Reports · 2026
© The Author(s) 20262026https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Cairo UniversityOpen access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T00:11:05.138778+00:00
DOI: 10.1038/s41598-026-35775-0 · PMC12873125